Kineta News June 28, 2022Kineta Announces Appointment of Thierry Guillaudeux, PhD to Chief Scientific Officer >> June 28, 2022Kineta Announces Appointment of Thierry Guillaudeux, PhD to Chief Scientific OfficerJune 17, 2022Kineta Presents New Preclinical Data and Phase 1/2 Clinical Trial Design of KVA12.1 at the Tumor Myeloid-Directed Therapies Summit >> June 17, 2022Kineta Presents New Preclinical Data and Phase 1/2 Clinical Trial Design of KVA12.1 at the Tumor Myeloid-Directed Therapies SummitJune 7, 2022Puget Sound Business Journal: Seattle biotech Kineta to go public in reverse merger deal with Yumanity Therapeutics >> June 7, 2022Puget Sound Business Journal: Seattle biotech Kineta to go public in reverse merger deal with Yumanity Therapeutics
